← Eichor
Study identifier: NCT06972446 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

Condition: Rheumatoid Arthritis  ·  Sponsor: AbbVie

PhasePhase 2
Planned participants180
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Rheumatoid Arthritis (RA) is a chronic inflammatory disease causing pain, stiffness, swelling and loss of joint function. This study will evaluate the efficacy and safety of targeted therapies through a series of substudies for the treatment of moderately to severely active Rheumatoid Arthritis (RA). This study currently includes 3 substudies evaluating different treatments in participants with RA. Substudy 1 will evaluate lutikizumab monotherapy (treatment given alone) compared to placebo (looks like the study treatment but contains no medicine). Substudy 2 will evaluate ravagalimab monotherapy compared to placebo and Substudy 3 will evaluate lutikizumab and ravagalimab combination therapy (treatments given together) compared to placebo. Approximately 180 participants who have failed 1 or 2 biologic/targeted synthetic disease-modifying antirheumatic drug (tsDMARD) therapies will be enrolled in the study at approximately 65 sites worldwide. There may be higher treatment burden for participants in this trial compared to their standard of care treatment without participating in this study. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.

This description comes directly from the study's public registry record.

Talk to the study team

ABBVIE CALL CENTER  ·  844-663-3742  ·  abbvieclinicaltrials@abbvie.com

Always discuss trial participation with your own doctor first.

Locations (104)

Sun Valley Arthritis Center /ID# 278331Peoria, Arizona, United StatesRecruiting
Arensia Research Clinic /ID# 280896Phoenix, Arizona, United StatesNot Yet Recruiting
Arthritis And Rheumatism Associates (Ara) - Jonesboro /ID# 272896Jonesboro, Arkansas, United StatesRecruiting
Private Practice - Dr. David S. Hallegua /ID# 277608Beverly Hills, California, United StatesRecruiting
Advanced Clinical Research Center, LLC dba TriWest Research Associates /ID# 277826Chula Vista, California, United StatesRecruiting
Newport Huntington Medical Group /ID# 272439Huntington Beach, California, United StatesRecruiting
Cohen Medical Centers /ID# 278341Thousand Oaks, California, United StatesRecruiting
The Lundquist Institute /ID# 272481Torrance, California, United StatesRecruiting
Inland Rheumatology and Osteoporosis Medical Group /ID# 272449Upland, California, United StatesRecruiting
Tekton Research - Fort Collins - East Harmony Road /ID# 272472Fort Collins, Colorado, United StatesRecruiting
Highlands Advanced Rheumatology And Arthritis Center - Avon Park /ID# 272298Avon Park, Florida, United StatesRecruiting
Clinical Research Of West Florida - Phase I Unit /ID# 272428Clearwater, Florida, United StatesRecruiting

+ 92 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06972446